Sorrento Therapeutics

Sorrento Therapeutics

World Rank (Jan-05-2024)
18,628
World Rank (Jul-30-2023)
18,628
Market Cap (Jul-30-2023)
0.179 Billion USD
World Rank (Jan-07-2022)
7,756
Market Cap (Jan-07-2022)
1.388 Billion USD
World Rank (Jan-01-2021)
5,684
Market Cap (Jan-01-2021)
1.868 Billion USD
Headquarters Country
USA
Employee Count
799
Employee Count as of Date
As on 2021
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
52 Million USD
Annual Net Income in USD
-428 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
694 Million USD
Total Liabilities in USD
616 Million USD
Total Equity in USD
78 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector
Healthcare
Biotechnology
Technology
HealthCare Products
Company Website
SORRENTO THERAPEUTICS
Company Profile

Sorrento Therapeutics is a Biotechnology company assets are complemented by an innovative lymphatic targeting device designed to deliver antibodies into the lymphatic system where immune cells are trained to fight cancer. The company annual revenue is 31 million USD and 382 employees as on 2020. The headquarters is in USA.

Founded Year
1989
Stock Exchange
Nasdaq

Share